Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats
Related Experiment Video
Updated: Oct 2, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Chan Gao1, Xiao Fei1, Ming Wang1
1Departmemt of Nephrology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine. Hangzhou, Zhejiang 310000, PR China.
Background:
Diabetic nephropathy is one of the common complications of diabetes mellitus, which seriously affects the life quality and health of patients. In this study, we aimed to investigate the function of cardamonin (CAD) in diabetes-induced kidney damage in rats.
Methods:
The normal rat kidney tubular epithelial cells (NRK-52E) were pre-treated with different doses of CAD and then stimulated with methylglyoxal (MGO). Streptozotocin (STZ) induced diabetes rat model were received different doses of CAD treatment. MTT, EdU, Transwell, and flow cytometry was used to detect cell viability, proliferation, migration, and apoptosis. Western blot analysis was used to detect the expression of apoptosis related proteins, advanced glycation end-products (AGEs), receptor for AGEs (RAGE), epithelial mesenchymal transition (EMT) related proteins, phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway related proteins, and janus kinas/signal transducer and activator of transcription 3 (JAK/STAT3) related proteins. ELISA assay was used to detect the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β). The levels of malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) were detected using commercial kit. Hematoxylin and eosin staining was used to assess pathological changes in rat kidney.
Results:
Compared with control group, MGO reduced cell viability and proliferation, enhanced migration and apoptosis of NRK-52E cells, while CAD inhibited these effects induced by MGO in NRK-52E cells. Moreover, CAD increased Bcl-2 expression and decreased the expression of Bax and cleaved caspase-3 in MGO-treated NRK-52E cells. Compared with control group, MGO increased the AGEs formation, the expression of RAGE and p-p65, the levels of TNF-α, IL-6, IL-1β, MDA in NRK-52E cells and reduced the levels of GSH and SOD, while treatment of CAD dose-dependently prevented these results. In addition, CAD attenuated MGO-induced EMT of MGO-treated NRK-52E cells. Mechanically, we identified that CAD repressed PI3K/AKT and JAK/STAT3 signaling in NRK-52E cells. Importantly, the kidney injury of diabetes rats was attenuated by CAD. Besides, STZ-induced inflammatory response, oxidative stress, and phosphorylation levels of PI3K, AKT, JAK2, and STAT3 were reduced by CAD in the rats.
Conclusion:
CAD protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats.
Insights
Cardamonin (CAD) protects against diabetic kidney damage by reducing inflammation and oxidative stress. It modulates key signaling pathways, offering a potential therapeutic strategy for diabetic nephropathy.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Diabetic nephropathy is a severe complication of diabetes mellitus, impacting patient quality of life.
- Investigating protective agents against diabetes-induced kidney damage is crucial.
Purpose of the Study:
- To investigate the protective effects of cardamonin (CAD) on diabetes-induced kidney damage in a rat model.
- To elucidate the underlying molecular mechanisms of CAD's action.
Main Methods:
- Utilized methylglyoxal (MGO) and streptozotocin (STZ) to induce kidney damage in rat kidney cells (NRK-52E) and rats, respectively.
- Assessed cell viability, proliferation, migration, and apoptosis using MTT, EdU, Transwell, and flow cytometry.
- Analyzed protein expression (AGEs, RAGE, EMT, PI3K/AKT, JAK/STAT3), inflammatory cytokines (TNF-α, IL-6, IL-1β), oxidative stress markers (MDA, GSH, SOD), and kidney pathology.
Main Results:
- CAD treatment inhibited MGO-induced apoptosis, migration, and enhanced proliferation in NRK-52E cells.
- CAD reduced advanced glycation end-products (AGEs), receptor for AGEs (RAGE), inflammatory cytokines, and oxidative stress markers in vitro and in vivo.
- CAD attenuated epithelial-mesenchymal transition (EMT) and suppressed PI3K/AKT and JAK/STAT3 signaling pathways.
Conclusions:
- Cardamonin (CAD) demonstrates significant protective effects against diabetes-induced kidney damage.
- CAD exerts its protective functions by modulating PI3K/AKT and JAK/STAT signaling pathways, reducing inflammation and oxidative stress.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention
The JAK-STAT Signaling Pathway